Results 121 to 130 of about 16,279,763 (246)
Characterization of Desmoglein-3 Epitope Region Peptides as Synthetic Antigens: Analysis of their in vitro T-cell Stimulating Efficacy, Cytotoxicity, Stability and their Conformational Features [PDF]
Desmoglein-3 (Dsg3) adhesion protein is the main target of autoantibodies and autoreactive T cells in Pemphigus vulgaris (PV) autoimmune skin disorder.
Ahmed+53 more
core +1 more source
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome [PDF]
Tumors can develop a blood supply not only by promoting angiogenesis but also by forming vessel-like structures directly from tumor cells, known as vasculogenic mimicry (VM).
Bonder, C.+14 more
core +1 more source
Oncolytic Immunotherapy: Where Are We Clinically? [PDF]
Peer ...
Hemminki, Akseli
core +2 more sources
Proteomic analysis of skin invasion by blood fluke larvae. [PDF]
BackgroundDuring invasion of human skin by schistosome blood fluke larvae (cercariae), a multicellular organism breaches the epidermis, basement membrane, and dermal barriers of skin.
Braschi, Simon+7 more
core +1 more source
Lesions of pemphigus vulgaris on irradiated skin [PDF]
Summary Pemphigus vulgaris (PV) is an autoimmune blistering disease produced by IgG autoantibodies against desmoglein (Dsg)3. Lesions on the skin and mucosa can, in rare cases, be induced by radiotherapy.
Aguado, L. (Leyre)+4 more
core +1 more source
OBJECTIVES/SPECIFIC AIMS: Pemphigus vulgaris (PV) is a potentially fatal blistering disease caused by autoantibodies to the keratinocyte adhesion protein desmoglein 3.
Nina Ran+3 more
doaj +1 more source
Background Walking along disease-associated protein sequences in the search for specific segments able to induce cellular immune response may direct clinical research towards effective peptide-based vaccines.
Kanduc Darja+4 more
doaj +1 more source
Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. [PDF]
Masayuki Amagai+4 more
openalex +1 more source
JEADV Clinical Practice, Volume 4, Issue 2, Page 580-583, June 2025.
Shirley P. Parraga+3 more
wiley +1 more source